Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Neoplasms 2Brain Neoplasms 2Sarcoma 1Pituitary Neoplasms 1Osteosarcoma 1Oligodendroglioma 1Neurotoxicity Syndromes 1Neurofibromatosis 1 1Multiple Myeloma 1Meningioma 1Lymphoma, Non-Hodgkin 1Lymphoma, B-Cell 1Lung Neoplasms 1Hodgkin Disease 1Glioma 1Fatigue 1Cytokine Release Syndrome 1Astrocytoma 1

Interventions

Methotrexate 3Ifosfamide 3Cisplatin 3Magnetic Resonance Spectroscopy 2Leucovorin 2Electroacupuncture 2Doxorubicin 2sargramostim 1regorafenib 1delta 24-sterol reductase 1apatinib 1Tissue and Organ Procurement 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Standard of Care 1Resistance Training 1Radiotherapy, Image-Guided 1Proton Therapy 1Positron Emission Tomography Computed Tomography 1Physical Therapy Modalities 1Pentetic Acid 1Palliative Care 1Nutritional Support 1Neuropsychological Tests 1Neoadjuvant Therapy 1Minocycline 1Mesna 1Heparin 1Granulocyte-Macrophage Colony-Stimulating Factor 1Glutamine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Osteosarcoma × Neuropsychological Tests × Clear all
NCT02309242 2015-08-21

Long Term Neurotoxic Effects of Chemotherapy in Survivors of Bone and Soft Tissue Sarcomas. A Retrospective Study

Universitaire Ziekenhuizen KU Leuven

Phase NA Unknown
60 enrolled
Sarcoma

Sarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡